2026/655

16.4.2026

DECISION OF THE EEA JOINT COMMITTEE No 279/2025

of 5 December 2025

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/655]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Regulation (EU) 2025/929 of 21 May 2025 approving 1,2-Benzisothiazol-3(2H)-one (BIT) as an existing active substance for use in biocidal products of product-types 6 and 13 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 1 ) is to be incorporated into the EEA Agreement.

(2) Commission Implementing Regulation (EU) 2025/937 of 21 May 2025 approving 2,2-Dibromo-2-cyanoacetamide (DBNPA) as an existing active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 2 ) is to be incorporated into the EEA Agreement.

(3) Commission Implementing Regulation (EU) 2025/1043 of 26 May 2025 approving formic acid as an existing active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 3 ) is to be incorporated into the EEA Agreement.

(4) Commission Implementing Decision (EU) 2025/944 of 22 May 2025 postponing the expiry date of the approval of DDACarbonate for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 4 ) is to be incorporated into the EEA Agreement.

(5) Commission Implementing Decision (EU) 2025/945 of 22 May 2025 postponing the expiry date of the approval of nonanoic acid for use in biocidal products of product-type 2 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 5 ) is to be incorporated into the EEA Agreement.

(6) Commission Implementing Decision (EU) 2025/947 of 22 May 2025 postponing the expiry date of the approval of iodine for use in biocidal products of product-type 3 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 6 ) is to be incorporated into the EEA Agreement.

(7) Commission Implementing Decision (EU) 2025/949 of 22 May 2025 postponing the expiry date of the approval of decanoic acid for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 7 ) is to be incorporated into the EEA Agreement.

(8) Commission Implementing Decision (EU) 2025/950 of 22 May 2025 postponing the expiry date of the approval of 1R-trans phenothrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 8 ) is to be incorporated into the EEA Agreement.

(9) Commission Implementing Decision (EU) 2025/951 of 22 May 2025 postponing the expiry date of the approval of polyvinylpyrrolidone iodine for use in biocidal products of product-types 1 and 3 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 9 ) is to be incorporated into the EEA Agreement.

(10) Commission Implementing Decision (EU) 2025/952 of 22 May 2025 postponing the expiry date of the approval of S-methoprene for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 10 ) is to be incorporated into the EEA Agreement.

(11) Commission Implementing Decision (EU) 2025/953 of 23 May 2025 postponing the expiry date of the approval of medetomidine for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 11 ) is to be incorporated into the EEA Agreement.

(12) Commission Implementing Decision (EU) 2025/970 of 22 May 2025 postponing the expiry date of the approval of IPBC for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 12 ) is to be incorporated into the EEA Agreement.

(13) Commission Implementing Decision (EU) 2025/998 of 22 May 2025 postponing the expiry date of the approval of bis(N-cyclohexyl-diazenium-dioxy)-copper (Cu-HDO) for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 13 ) is to be incorporated into the EEA Agreement.

(14) Commission Implementing Decision (EU) 2025/1074 of 2 June 2025 not approving ethylene oxide as an existing active substance for use in biocidal products of product-type 2 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council  ( 14 ) is to be incorporated into the EEA Agreement.

(15) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following points are inserted after point 12zzzzzzzzzzzzl (Commission Implementing Decision (EU) 2025/1812) of Chapter XV of Annex II to the EEA Agreement:

‘12zzzzzzzzzzzzm.

32025 R 0929 : Commission Implementing Regulation (EU) 2025/929 of 21 May 2025 approving 1,2-Benzisothiazol-3(2H)-one (BIT) as an existing active substance for use in biocidal products of product-types 6 and 13 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L, 2025/929, 22.5.2025 ).

12zzzzzzzzzzzzn.

32025 R 0937 : Commission Implementing Regulation (EU) 2025/937 of 21 May 2025 approving 2,2-Dibromo-2-cyanoacetamide (DBNPA) as an existing active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L, 2025/937, 22.5.2025 ).

12zzzzzzzzzzzzo.

32025 R 1043 : Commission Implementing Regulation (EU) 2025/1043 of 26 May 2025 approving formic acid as an existing active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L, 2025/1043, 27.5.2025 ).

12zzzzzzzzzzzzp.

32025 D 0944 : Commission Implementing Decision (EU) 2025/944 of 22 May 2025 postponing the expiry date of the approval of DDACarbonate for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L, 2025/944, 23.5.2025 ).

12zzzzzzzzzzzzq.

32025 D 0945 : Commission Implementing Decision (EU) 2025/945 of 22 May 2025 postponing the expiry date of the approval of nonanoic acid for use in biocidal products of product-type 2 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L, 2025/945, 23.5.2025 ).

12zzzzzzzzzzzzr.

32025 D 0947 : Commission Implementing Decision (EU) 2025/947 of 22 May 2025 postponing the expiry date of the approval of iodine for use in biocidal products of product-type 3 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L, 2025/947, 23.5.2025 ).

12zzzzzzzzzzzzs.

32025 D 0949 : Commission Implementing Decision (EU) 2025/949 of 22 May 2025 postponing the expiry date of the approval of decanoic acid for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L, 2025/949, 26.5.2025 ).

12zzzzzzzzzzzzt.

32025 D 0950 : Commission Implementing Decision (EU) 2025/950 of 22 May 2025 postponing the expiry date of the approval of 1R-trans phenothrin for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L, 2025/950, 26.5.2025 ).

12zzzzzzzzzzzzu.

32025 D 0951 : Commission Implementing Decision (EU) 2025/951 of 22 May 2025 postponing the expiry date of the approval of polyvinylpyrrolidone iodine for use in biocidal products of product-types 1 and 3 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L, 2025/951, 26.5.2025 ).

12zzzzzzzzzzzzv.

32025 D 0952 : Commission Implementing Decision (EU) 2025/952 of 22 May 2025 postponing the expiry date of the approval of S-methoprene for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L, 2025/952, 23.5.2025 ).

12zzzzzzzzzzzzw.

32025 D 0953 : Commission Implementing Decision (EU) 2025/953 of 23 May 2025 postponing the expiry date of the approval of medetomidine for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L, 2025/953, 23.5.2025 ).

12zzzzzzzzzzzzx.

32025 D 0970 : Commission Implementing Decision (EU) 2025/970 of 22 May 2025 postponing the expiry date of the approval of IPBC for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L, 2025/970, 23.5.2025 ).

12zzzzzzzzzzzzy.

32025 D 0998 : Commission Implementing Decision (EU) 2025/998 of 22 May 2025 postponing the expiry date of the approval of bis(N-cyclohexyl-diazenium-dioxy)-copper (Cu-HDO) for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L, 2025/998, 23.5.2025 ).

12zzzzzzzzzzzzz.

32025 D 1074 : Commission Implementing Decision (EU) 2025/1074 of 2 June 2025 not approving ethylene oxide as an existing active substance for use in biocidal products of product-type 2 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L, 2025/1074, 3.6.2025 ).’

Article 2

The texts of Implementing Regulations (EU) 2025/929, (EU) 2025/937 and (EU) 2025/1043 and Implementing Decisions (EU) 2025/944, (EU) 2025/945, (EU) 2025/947, (EU) 2025/949, (EU) 2025/950, (EU) 2025/951, (EU) 2025/952, (EU) 2025/953, (EU) 2025/970, (EU) 2025/998 and (EU) 2025/1074 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 6 December 2025, provided that all the notifications under Article 103(1) of the EEA Agreement have been made  ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 5 December 2025.

For the EEA Joint Committee

The President

Stefán Haukur JÓHANNESSON

( 1 )    OJ L, 2025/929, 22.5.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/929/oj .

( 2 )    OJ L, 2025/937, 22.5.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/937/oj .

( 3 )    OJ L, 2025/1043, 27.5.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/1043/oj .

( 4 )    OJ L, 2025/944, 23.5.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/944/oj .

( 5 )    OJ L, 2025/945, 23.5.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/945/oj .

( 6 )    OJ L, 2025/947, 23.5.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/947/oj .

( 7 )    OJ L, 2025/949, 26.5.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/949/oj .

( 8 )    OJ L, 2025/950, 26.5.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/950/oj .

( 9 )    OJ L, 2025/951, 26.5.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/951/oj .

( 10 )    OJ L, 2025/952, 23.5.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/952/oj .

( 11 )    OJ L, 2025/953, 23.5.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/953/oj .

( 12 )    OJ L, 2025/970, 23.5.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/970/oj .

( 13 )    OJ L, 2025/998, 23.5.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/998/oj .

( 14 )    OJ L, 2025/1074, 3.6.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/1074/oj .

( *1 )   No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2026/655/oj

ISSN 1977-0677 (electronic edition)